🇺🇸 FDA
Patent

US 10023587

Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

granted A61KA61K31/203A61K31/496

Quick answer

US patent 10023587 (Oxabicycloheptanes and oxabicycloheptenes, their preparation and use) held by Lixte Biotechnology, Inc. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/203, A61K31/496, A61P, A61P31/10